Zhi Shi - Publications, H-index & Citations

Zhi Shi

jinan university

47H指数

212论文数

5.3K被引数

收录论文 64

发表时间

Tri- and Difluoromethylated Spiro[5.5]trienones Inhibit the Growth of Cancer Cells In Vitro and In Vivo 三氟甲基化和二氟甲基化的螺[5.5]三烯酮在体外和体内抑制癌细胞生长

Biomedicines

IF3.9

2026-04-04

OAAI

Zhong-Bao Shao; Xiao-Peng Song; Ying-Ying Wang; Yi-Yao Shan; Yu-Meng Xiong; Ke He; Yan Zhang; Zhi Shi

Phase separation of Snail1 modulates transcription and cancer progression Snail1的相分离调节转录和癌症进展

Genes & Diseases

IF9.4

2026-03-17

OAAI

Yi-Ping Huang; Peng-Wei Zhang; Ke He; Zhong-Bao Shao; Wei-Jing Liu; You-Qing Zhu; Shi-Jie Zeng; Zhi Shi

An Integrative Roadmap for Advancing Colorectal Cancer Organoid

Biomedicines

IF3.9

2026-01-24

OAAI

Youqing Zhu; Ke He; Zhi Shi

H89 Reverses Multidrug Resistance in Colorectal Cancer by Inhibiting the ATPase Activity of ABCB1 H89通过抑制ABCB1的ATPase活性逆转结直肠癌的多药耐药性

Biomedicines 2025, Vol. 13, Page 2869

IF3.9

2025-11-25

OAAI

Wei-Jing Liu; Yi-Yao Shan; Huan Wang; Yu-Meng Xiong; Le-Yao Shi; Xiao-Peng Song; Min Li; Ke He; Jia Huang; Zhi Shi

The Role of Tumor Microenvironment and Signaling Pathways in Regulating Breast Cancer Stem Cells: Implications for Therapy Resistance and Tumor Recurrence 肿瘤微环境与信号通路在调控乳腺癌干细胞中的作用：对治疗抵抗和肿瘤复发的影响

Drug Resistance Updates

IF21.7

2025-10-13

PREAI

Hongbo Zhang; Yue Sun; Rui Liu; Hayam Hamdy; Zhi Shi; Dewei Jiang; Jianwei Sun

Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial 信迪利单抗联合安罗替尼与序贯化疗治疗晚期三阴性乳腺癌（SPACE）的疗效与安全性：一项单臂、多中心II期研究的初步结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Li, H.; Zhou, D.; Yv, Z.; Liao, Y.; Huang, J.; Sun, S.; Zheng, F.; Li, B.; Fang, S.; Qiang, L.; Ren, G.; Wang, X.; Baoxuan, Z.; Fan, B.; Zhao, X.; Li, W.; Wang, Z.; Fu, H.; Sun, X.; Shi, Z.

Phase separation of RNF214 promotes the progression of hepatocellular carcinoma

CELL DEATH & DISEASE

IF9.6

2024-07-05

OAAI

He, Zheng-Jie; He, Ke; Cai, Song-Wang; Zhang, Rui; Shao, Zhong-Bao; Wang, Sheng-Te; Li, Xiao-Peng; Li, Yan-Chi; Liu, Wei-Jing; Zhu, You-Qing; Zeng, Shi-Jie; Su, Yu-Bin; Shi, Zhi

THZ2 Ameliorates Mouse Colitis and Colitis-Associated Colorectal Cancer

BIOMEDICINES

IF3.9

2024-03-18

OAAI

Wang, Sheng-Te; Wang, Ying-Ying; Huang, Jia-Rong; Shu, Yu-Bin; He, Ke; Shi, Zhi

Small-molecule agents for cancer immunotherapy

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-03-01

OAAI

Wang, Fang; Fu, Kai; Wang, Yujue; Pan, Can; Wang, Xueping; Liu, Zeyu; Yang, Chuan; Zheng, Ying; Li, Xiaopeng; Lu, Yu; To, Kenneth Kin Wah; Xia, Chenglai; Zhang, Jianye; Shi, Zhi; Hu, Zeping; Huang, Min; Fu, Liwu

GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-02-01

OAAI

Jiang, Qiwei; Li, Yong; Cai, Songwang; Shi, Xingyuan; Yang, Yang; Xing, Zihao; He, Zhenjie; Wang, Shengte; Su, Yubin; Chen, Meiwan; Chen, Zhesheng; Shi, Zhi

GSK2606414 Sensitizes ABCG2-Overexpressing Multidrug-Resistant Colorectal Cancer Cells to Chemotherapeutic Drugs

BIOMEDICINES

IF3.9

2023-11-20

OAAI

Yu, Ze-Zhong; Xu, Bu-Qing; Wang, Ying-Ying; Zhang, Peng-Wei; Shu, Yu-Bin; Shi, Zhi

Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC

DRUG RESISTANCE UPDATES

IF21.7

2023-09-01

OAAI

Liu, Wen-Jing; Wang, Lin; Zhou, Feng-Mei; Liu, Shu-Wen; Wang, Wei; Zhao, Er-Jiang; Yao, Quan-Jun; Li, Wei; Zhao, Yan-Qiu; Shi, Zhi; Qiu, Jian-Ge; Jiang, Bing-Hua

ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy

ACTA BIOMATERIALIA

IF9.6

2022-03-01

PREAI

Yang, Suleixin; Hua, Peng; He, Chengwei; Yu, Hua; Shao, Dan; Shi, Zhi; Chen, Meiwan; Wong, Ka Hong

USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets

BIOMEDICINES

IF3.9

2022-02-17

OAAI

Li, Yan-Chi; Cai, Song-Wang; Shu, Yu-Bin; Chen, Mei-Wan; Shi, Zhi

Enhancement of anticancer drug sensitivity in multidrug resistance cells overexpressing ATP-binding cassette (ABC) transporter ABCC10 by CP55, a synthetic derivative of 5-cyano-6-phenylpyrimidin

EXPERIMENTAL CELL RESEARCH

IF3.5

2021-08-01

PREAI

Wang, Jing-Quan; Wang, Bo; Ma, Li-Ying; Shi, Zhi; Liu, Hong-Min; Liu, Zhijun; Chen, Zhe-Sheng

CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)

BIOCHEMICAL PHARMACOLOGY

IF5.6

2021-08-01

PREAI

Wang, Jing-Quan; Wang, Bo; Teng, Qiu-Xu; Lei, Zi-Ning; Li, Yi-Dong; Shi, Zhi; Ma, Li-Ying; Liu, Hong-Min; Liu, Zhijun; Chen, Zhe-Sheng

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-20

OAAI

Liu, Kun; Li, Yan-Chi; Chen, Yu; Shi, Xiao-Bao; Xing, Zi-Hao; He, Zheng-Jie; Wang, Sheng-Te; Liu, Wei-Jing; Zhang, Peng-Wei; Yu, Ze-Zhong; Mo, Xue-Mei; Chen, Mei-Wan; Chen, Zhe-Sheng; Shi, Zhi

Determination of the Absolute Configuration of Super-Carbon-Chain Compounds by a Combined Chemical, Spectroscopic, and Computational Approach: Gibbosols A and B

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2020-06-03

PREAI

Li, Wan-Shan; Yan, Ren-Jie; Yu, Yi; Shi, Zhi; Mandi, Attila; Shen, Li; Kurtan, Tibor; Wu, Jun

Multi-omic analysis reveals HIP-55-dependent regulation of cytokines release

BIOSCIENCE REPORTS

IF4.7

2020-03-20

OAAI

Jiang, Yunqi; Xing, Zihao; Zhu, Baolin; Wang, Wenjing; Sun, Yang; Shi, Zhi; Li, Zijian

miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78

FRONTIERS IN ONCOLOGY

IF3.3

2020-02-04

OAAI

Lin, Xi-Jun; Liu, Hui; Li, Pei; Wang, Hai-Feng; Yang, An-Kui; Di, Jin-Ming; Jiang, Qi-Wei; Yang, Yang; Huang, Jia-Rong; Yuan, Meng-Ling; Xing, Zi-Hao; Wei, Meng-Ning; Li, Yao; Shi, Zhi; Ye, Jin

研究方向